SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-22-001301
Filing Date
2022-08-09
Accepted
2022-08-09 16:31:53
Documents
44
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e3945_10q.htm   iXBRL 10-Q 777287
2 EXHIBIT 31.1 e3945_ex31-1.htm EX-31.1 10971
3 EXHIBIT 31.2 e3945_ex31-2.htm EX-31.2 11176
4 EXHIBIT 32.1 e3945_ex32-1.htm EX-32.1 8053
5 GRAPHIC image_001.jpg GRAPHIC 34369
6 GRAPHIC image_002.jpg GRAPHIC 28414
  Complete submission text file 0001731122-22-001301.txt   3358648

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE avxl-20220630.xsd EX-101.SCH 28318
8 XBRL CALCULATION FILE avxl-20220630_cal.xml EX-101.CAL 29314
9 XBRL DEFINITION FILE avxl-20220630_def.xml EX-101.DEF 92917
10 XBRL LABEL FILE avxl-20220630_lab.xml EX-101.LAB 217668
11 XBRL PRESENTATION FILE avxl-20220630_pre.xml EX-101.PRE 164040
38 EXTRACTED XBRL INSTANCE DOCUMENT e3945_10q_htm.xml XML 463796
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 221148849
SIC: 2836 Biological Products, (No Diagnostic Substances)